NCT04328766View on ClinicalTrials.gov

Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 6, 2020

Primary Completion Date

November 21, 2020

Study Completion Date

November 21, 2020

Conditions
Drug-drug Interaction
Interventions
DRUG

DWC202005, alone

DWC202005, as a single dose

DRUG

DWP14012 + DWC202005

DWP14012 and DWC202005, as a single dose

DRUG

DWP14012 + DWC202005, after multiple doses of DWP14012

DWP14012 and DWC202005, after multiple oral doses of DWP14012 once daily for 12 days

Trial Locations (1)

78

Nucleus Network (QPharm), Queensland

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY